This research aims to evaluate the effectiveness of percutaneous transluminal pulmonary angioplasty in treating chronic thromboembolic pulmonary hypertension.
Conducted a randomized trial with a unique identifier (UMIN000001572).
Used interventions targeting the pulmonary arteries in patients with chronic thromboembolic conditions.
Analyzed treatment outcomes based on changes in pulmonary pressures and patient symptoms.
Demonstrated significant improvements in pulmonary arterial pressure post-angioplasty.
Identified positive changes in symptoms associated with chronic thromboembolic pulmonary hypertension.